JP5423200B2 - 分析チップおよび検体の分析方法 - Google Patents
分析チップおよび検体の分析方法 Download PDFInfo
- Publication number
- JP5423200B2 JP5423200B2 JP2009170146A JP2009170146A JP5423200B2 JP 5423200 B2 JP5423200 B2 JP 5423200B2 JP 2009170146 A JP2009170146 A JP 2009170146A JP 2009170146 A JP2009170146 A JP 2009170146A JP 5423200 B2 JP5423200 B2 JP 5423200B2
- Authority
- JP
- Japan
- Prior art keywords
- holding tank
- analysis chip
- reaction chamber
- rotation
- rotation speed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004458 analytical method Methods 0.000 title claims description 214
- 238000012284 sample analysis method Methods 0.000 title claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 157
- 239000003153 chemical reaction reagent Substances 0.000 claims description 99
- 238000005259 measurement Methods 0.000 claims description 79
- 230000005484 gravity Effects 0.000 claims description 52
- 239000000126 substance Substances 0.000 claims description 51
- 238000000034 method Methods 0.000 claims description 32
- 239000000427 antigen Substances 0.000 claims description 31
- 102000036639 antigens Human genes 0.000 claims description 31
- 108091007433 antigens Proteins 0.000 claims description 31
- 230000009471 action Effects 0.000 claims description 20
- 230000001900 immune effect Effects 0.000 claims description 20
- 230000002401 inhibitory effect Effects 0.000 claims description 20
- 238000011144 upstream manufacturing Methods 0.000 claims description 7
- 230000002209 hydrophobic effect Effects 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 5
- 238000004891 communication Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 description 146
- 239000000523 sample Substances 0.000 description 55
- 239000000243 solution Substances 0.000 description 49
- 238000000926 separation method Methods 0.000 description 41
- 102000004190 Enzymes Human genes 0.000 description 36
- 108090000790 Enzymes Proteins 0.000 description 36
- 239000000758 substrate Substances 0.000 description 33
- 210000004369 blood Anatomy 0.000 description 30
- 239000008280 blood Substances 0.000 description 30
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 27
- 239000004926 polymethyl methacrylate Substances 0.000 description 27
- 230000002093 peripheral effect Effects 0.000 description 21
- 230000027455 binding Effects 0.000 description 20
- 238000009739 binding Methods 0.000 description 20
- -1 or net Substances 0.000 description 20
- 239000000725 suspension Substances 0.000 description 20
- 239000013543 active substance Substances 0.000 description 18
- 239000012472 biological sample Substances 0.000 description 16
- 238000004140 cleaning Methods 0.000 description 16
- 239000011324 bead Substances 0.000 description 14
- 210000000601 blood cell Anatomy 0.000 description 14
- 238000003018 immunoassay Methods 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 238000010586 diagram Methods 0.000 description 13
- 210000002966 serum Anatomy 0.000 description 13
- 239000013076 target substance Substances 0.000 description 13
- 239000011259 mixed solution Substances 0.000 description 12
- 108090001007 Interleukin-8 Proteins 0.000 description 11
- 239000004743 Polypropylene Substances 0.000 description 11
- 239000003112 inhibitor Substances 0.000 description 11
- 239000002245 particle Substances 0.000 description 11
- 229920001155 polypropylene Polymers 0.000 description 11
- 238000007667 floating Methods 0.000 description 10
- 238000005406 washing Methods 0.000 description 10
- 239000011347 resin Substances 0.000 description 9
- 229920005989 resin Polymers 0.000 description 9
- 239000011325 microbead Substances 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 8
- 102000003992 Peroxidases Human genes 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 238000001746 injection moulding Methods 0.000 description 6
- 108040007629 peroxidase activity proteins Proteins 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 5
- 239000004793 Polystyrene Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229920002223 polystyrene Polymers 0.000 description 5
- 229920001213 Polysorbate 20 Polymers 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 239000004417 polycarbonate Substances 0.000 description 4
- 229920000515 polycarbonate Polymers 0.000 description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
- 108090001008 Avidin Proteins 0.000 description 3
- 102000004856 Lectins Human genes 0.000 description 3
- 108090001090 Lectins Proteins 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000005660 hydrophilic surface Effects 0.000 description 3
- 230000005661 hydrophobic surface Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000002523 lectin Substances 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000003127 radioimmunoassay Methods 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PKYCWFICOKSIHZ-UHFFFAOYSA-N 1-(3,7-dihydroxyphenoxazin-10-yl)ethanone Chemical compound OC1=CC=C2N(C(=O)C)C3=CC=C(O)C=C3OC2=C1 PKYCWFICOKSIHZ-UHFFFAOYSA-N 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000003850 cellular structure Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 238000003891 environmental analysis Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- QOSATHPSBFQAML-UHFFFAOYSA-N hydrogen peroxide;hydrate Chemical compound O.OO QOSATHPSBFQAML-UHFFFAOYSA-N 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000005375 photometry Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 102000003896 Myeloperoxidases Human genes 0.000 description 1
- 108090000235 Myeloperoxidases Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000005385 borate glass Substances 0.000 description 1
- 239000005388 borosilicate glass Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 229910002077 partially stabilized zirconia Inorganic materials 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000306 polymethylpentene Polymers 0.000 description 1
- 239000011116 polymethylpentene Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000004845 protein aggregation Effects 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000005368 silicate glass Substances 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Automatic Analysis And Handling Materials Therefor (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009170146A JP5423200B2 (ja) | 2009-07-21 | 2009-07-21 | 分析チップおよび検体の分析方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009170146A JP5423200B2 (ja) | 2009-07-21 | 2009-07-21 | 分析チップおよび検体の分析方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011027421A JP2011027421A (ja) | 2011-02-10 |
| JP2011027421A5 JP2011027421A5 (enExample) | 2012-08-23 |
| JP5423200B2 true JP5423200B2 (ja) | 2014-02-19 |
Family
ID=43636353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009170146A Active JP5423200B2 (ja) | 2009-07-21 | 2009-07-21 | 分析チップおよび検体の分析方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5423200B2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2653916T3 (es) | 2011-03-08 | 2018-02-09 | Universite Laval | Dispositivo centrípeto fluídico |
| JP5413429B2 (ja) * | 2011-09-07 | 2014-02-12 | ブラザー工業株式会社 | 検査システム、及び検査方法 |
| JP2013076588A (ja) * | 2011-09-29 | 2013-04-25 | Brother Ind Ltd | 受体ホルダおよび検査装置 |
| JP5585560B2 (ja) * | 2011-09-30 | 2014-09-10 | ブラザー工業株式会社 | 検査装置、検査方法、およびプログラム |
| CN112782393B (zh) * | 2013-03-11 | 2024-11-19 | 克忧健康公司 | 用于检测和量化分析物的系统和方法 |
| JP5958452B2 (ja) * | 2013-11-29 | 2016-08-02 | ブラザー工業株式会社 | 検査チップ |
| JP5910657B2 (ja) * | 2014-03-31 | 2016-04-27 | ブラザー工業株式会社 | 検査チップ及び検査システム |
| USD799715S1 (en) | 2015-10-23 | 2017-10-10 | Gene POC, Inc. | Fluidic centripetal device |
| KR101949380B1 (ko) * | 2016-03-31 | 2019-02-19 | (주) 인텍바이오 | 광산화 증폭을 이용한 고감도 바이오마커 정량 방법 |
| JP6773496B2 (ja) | 2016-09-16 | 2020-10-21 | 株式会社日立製作所 | 化学分析装置、前処理装置及び化学分析方法 |
| CN111122893B (zh) * | 2018-10-31 | 2024-04-12 | 天亮医疗器材股份有限公司 | 检测卡匣、检测方法及检测装置 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006112881A (ja) * | 2004-10-14 | 2006-04-27 | Nikkiso Co Ltd | 生体物質測定装置および生体物質測定装置用チップ |
| JP2006121935A (ja) * | 2004-10-27 | 2006-05-18 | Konica Minolta Medical & Graphic Inc | 前処理手段および廃液貯留部を有する生体物質検査用マイクロリアクタ |
| CA2706402C (en) * | 2007-11-20 | 2016-05-03 | Toray Industries, Inc. | Liquid-feeding chip and analysis method |
| JP5137010B2 (ja) * | 2007-11-28 | 2013-02-06 | ローム株式会社 | マイクロチップの製造方法 |
-
2009
- 2009-07-21 JP JP2009170146A patent/JP5423200B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011027421A (ja) | 2011-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5423200B2 (ja) | 分析チップおよび検体の分析方法 | |
| CN100503046C (zh) | 控制流动的测定装置和方法 | |
| US10859570B2 (en) | Methods for detecting an analyte using an analyte detection device | |
| TWI550274B (zh) | 微流體檢驗裝置及其運作方法 | |
| CN102472739B (zh) | 离心式微流装置和用于检测来自液体样本的分析物的方法 | |
| JP5502482B2 (ja) | 回転可能試験素子 | |
| CN102933968B (zh) | 离心微流体装置和用于免疫测定的方法 | |
| JP6013519B2 (ja) | 統合された電気化学的免疫測定に基づくマイクロ流体デバイス、及びその基板 | |
| US20110008776A1 (en) | Integrated separation and detection cartridge using magnetic particles with bimodal size distribution | |
| JP2009535635A (ja) | 化学的、生化学的、生物学的および物理学的分析、反応、アッセイなどのためのデバイスおよび方法 | |
| CN102652264A (zh) | 用于测量糖化血红蛋白的离心微流结构、用于测量糖化血红蛋白的离心微流装置和用于测量糖化血红蛋白的方法 | |
| JP3693680B2 (ja) | 磁性粒子を使用するアッセイ | |
| JP2009300433A (ja) | 分析チップ | |
| EP2031393A1 (en) | Sensor element for spr measurement | |
| JP5125680B2 (ja) | 分離チップおよび分離方法 | |
| WO2003025547A1 (en) | Method and device for screening analytes using surface plasmon resonance | |
| CN106796224B (zh) | 测试带组件 | |
| KR102504840B1 (ko) | 현장 사용을 위한 휴대용 전혈 전처리 장치 및 이를 이용한 전처리 방법 | |
| WO2016035197A1 (ja) | 電気化学免疫センサ用カートリッジ及びそれを用いた測定装置 | |
| US20090162944A1 (en) | Method of Measuring Biomolecular Reaction at Ultrahigh Speed | |
| EP1797426B1 (en) | Rapid monitoring system for blood groups and immunohematological reaction detection | |
| JP5407150B2 (ja) | 免疫分析方法 | |
| EP2338595A1 (en) | Device, method, and system for the quantitative detection of the presence of multiple target analytes. | |
| JP2008268194A (ja) | 分析方法 | |
| WO2005090998A1 (ja) | 攪拌方法、セルおよびこれを用いた測定装置、測定方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120710 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120710 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130515 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130528 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130725 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130924 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131003 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131029 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131111 |
|
| R151 | Written notification of patent or utility model registration |
Ref document number: 5423200 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |